This
section of our Web site
sponsored by:

HEMOPHILIA.ORG > BLEEDING DISORDERS INFO CENTER >
NEWLY DIAGNOSED
> TREATMENT RECOMMENDATIONS


Bleeding Sites | Psychosocial Issues |
Treatment Recommendations
| Baby & Toddler Tips |
Child Raising
| Parents FAQ | Hemophilia Treatment Centers |
Child Abuse Issues
| In School
| Camp Yearbook | NHF Youthworld |

Treatment Recommendations

In 1954 the National Hemophilia Foundation formed a medical advisory council to advance clinical care and promote hemophilia research. Now known as the Medical and Scientific Advisory Council (MASAC), this body establishes quality of care guidelines for the treatment of hemophilia and other bleeding disorders.

Issued in the form of recommendations, MASAC guidelines set the standard of care around the world. The scientists, physicians and other treatment professionals who comprise MASAC are internationally regarded as experts in the broad field of bleeding disorders research and care, AIDS, hepatitis, other infectious diseases and blood safety. MASAC meets twice a year to issue its recommendations, which are then approved by NHF's Board of Directors.

MASAC recommendations are posted on NHF's Web site, are available to callers through HANDI, NHF's information clearinghouse (800-42-HANDI or handi@hemophilia.org), and are published in NHF's HemAware magazine.

Click here to search the online database of MASAC treatment recommendations.

Disclaimer
The information contained on the NHF web site is provided for your general information only. NHF does not give medical advice or engage in the practice of medicine. NHF under no circumstances recommends particular treatment for specific individuals and in all cases recommends that you consult your physician or local treatment center before pursuing any course of treatment.
     All information and content on this web site are protected by copyright. All rights are reserved. Users are prohibited from modifying, copying, distributing, transmitting, displaying, publishing, selling, licensing, creating derivative works, or using any information available on or through the site for commercial or public purposes.